Medical Management of HIV/AIDS, Hepatitis, and COVID-19
This year, the HIV, ID & Global Medicine Division will be hosting the UCSF Medical Management of HIV/AIDS, Hepatitis and COVID-19 (MMAHC) course, a three-day continuing medical education (CME) conference in San Francisco from Thursday, December 8 to Saturday, December 10. Previously known as the Medical Management of HIV/AIDS and Hepatitis (MMAH) course, we have shifted gears to address the global pandemic.
The symposium provides focused and topical education and updates on HIV and COVID-19 for clinicians from around the world. Lectures and workshops are presented by leading clinicians and researchers.
Each year’s agenda reflects recent advances, discoveries, and emergent issues. The agenda is geared at a wide range of HIV providers, from novice to expert. Topics have included HIV prevention, pre-exposure prophylaxis (PrEP), antiretroviral therapy (ART) management, hepatitis treatment, other infections (STDs, HPV), and primary care management of HIV patients. Beginning in 2020, we have added a special focus on COVID-19.
The Medical Management of HIV/AIDS and COVID-19 Conference is presented by UCSF's Division of HIV, ID & Global Medicine at Zuckerberg San Francisco General Hospital and enrolls and provides CME credits for approximately 300 participants. It is chaired by Division Chief and Professor Diane Havlir, MD; Associate Professor Emeritus Meg Newman, MD; and Professor Annie Luetkemeyer, MD.
Learn more about this year’s Medical Management of HIV/AIDS and COVID Conference (MMAHC 2022) here. Visit for 2022's program and registration!